Fastmarkets, the industry-leading cross-commodity price reporting agency (PRA), has successfully completed another external assurance review…
-
-
Cloud/Data CenterHealthcare
Sectra launches next generation cloud portal to enhance clinical learning in medical education
International medical imaging IT and cybersecurity company Sectra (STO: SECT B) launches a new generation of its…
-
Joint Ventures
Execution of a binding agreement to establish a Max Stock chain of stores in Portugal and Spain
Further to that set forth in Section 1.29.1 of the Company’s 2021 annual report[1],…
-
Biotechnology
Chemomab Adds Highly Experienced Executives Further Strengthening Its R&D and Clinical Capabilities
Chemomab Therapeutics, Ltd. (Nasdaq: CMMB) (Chemomab), a clinical-stage biotechnology company focused on the discovery and…
-
Networking
Lakewood, Ohio, Expands ParkMobile Partnership in an Effort to Modernize Parking in the City
ParkMobile, the #1 parking app in North America, has expanded its partnership with the City of Lakewood,…
-
Happiest Minds Technologies Limited (NSE: HAPPSTMNDS), a ‘Born Digital. Born Agile’ company today announced…
-
Advertising & Promotion
Stagwell (STGW) Announces Exclusive Sponsorship of Creative Equals Business to Drive Gender Equity in the Creative C-Suite
Stagwell (NASDAQ: STGW), the challenger network built to transform marketing, today announced exclusive sponsorship of the…
-
Healthcare
Bioretec Ltd’s Half Year Report 2022 (unaudited): Strong sales growth and RemeOs™ registrations on-going
This is a summary of Bioretec Ltd’s half year report 2022. The complete half…
-
Healthcare
Full-Life Technologies Deepens Radioisotope Technology Expertise with Key Leadership Appointments and the Establishment of a Radioisotope Technology Advisory Board
Full-Life Technologies Co., Ltd. (“Full-Life”) today announced two key appointments to its Radioisotope Technology leadership…
-
Biotechnology
European Society for Organ Transplantation’s (ESOT) guidelines for desensitization treatment of highly sensitized kidney transplant patients published in Transplant International
Hansa Biopharma AB, ‘Hansa’ (Nasdaq: HNSA) (Stockholm: HNSA), pioneer in enzyme technology for rare immunological…
